Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Neuroscience

Astellas to acquire neural dust start-up Iota Biosciences

by Ryan Cross
October 24, 2020 | A version of this story appeared in Volume 98, Issue 41

 

Astellas will acquire the bioelectronics start-up Iota Biosciences for $127.5 million and up to $176.5 million in milestone payments. Iota is developing millimeter-sized bioelectronic devices, called neural dust. Wirelessly powered by ultrasound, the devices and could be implanted to monitor or stimulate nerves. The firm was founded in 2017 by University of California, Berkeley, engineers Michel Maharbiz and Jose Carmena. Astellas says it will invest $125 million in Iota’s technology over 5 years.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.